Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

NCT04532229 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: Nimotuzumab+CRT(concurrent IMRT and TMZ)

Sponsor

Biotech Pharmaceutical Co., Ltd.